Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | GervanoRA (GDS) Projects Global (11 mm) Psoriasis Market is expected to reach $16.65 billion by 2027According to a new Psoriasis report "GER0002PS - Psoriasis: Global Market Analysis 2016 and Forecast 2017-2027" published by GervanoRA Data Services (GDS), Global (11MM) Psoriasis market is expected to reach $16.65 billion by 2027.
Aditi Bandodkar, Research Analyst at GDS commented "Biosimilars in 2016 do not contribute much value in the global psoriasis market. Number of key players has launched Biosimilars in the market outside US. However, we at GervanoRA have estimated that US market is largely protected from Biosimilars upsurge for a larger portion of forecast period until 2024. By the end of forecast period, we believe that Biosimilars would barely touch $2.0 billion market size." Globally Psoriasis therapeutic market is growing at a significant rate during the forecast period. Psoriasis is a genetic auto-immune, chronic skin disorder, prevalent in about 3% of the world's total population. The leading companies in the Psoriasis market include Novartis, Johnson & Johnson, GSK, Merck, Roche, Pfizer, AstraZeneca, AbbVie, Eli Lilly & Company, Amgen. Bandodkar continued "Key players with mature branded drugs are adopting various Life Cycle Management (LCM) and promotional strategies to consolidate their market position and increase their overall market share. LCM strategies include conducting head-to-head trials against other premium products, indication expansion, targeting sub-psoriasis indications, targeting different age groups, geographical expansion and formulation updates." Biologic market in the US alone has generated more than $4.5 billion revenue in 2016. In EU, Germany is the largest market, followed by UK. Japan is estimated to be growing at a significant rate of 8.8%. Bandodkar added "Growing incidence cases helps the Psoriasis market to grow in the European countries." To Read GervanoRA's Psoriasis full report, please Click on the below link https://www.gervanora.com/ About GervanoRA GervanoRA Data Services LLP is a premier provider of syndicated research reports, custom research reports and consulting services, based in Goa, India. GDS aims to deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial views of the competitive framework, and future market trends. At GervanoRA Data Services, we're playing our part to help clients stay ahead of the curve. We collaboratively work with a wide range of organizations (KOLs) to garner valuable key insights. To assist our global clients to attain their segment, sub segment specific goals, we are more enlightening them on domine specific live updates through our GervanoRA 360 DegreePharmMedTech Monthly Report which serve our clients with bespoke requirements without missing any live update for the particular month, as we know how valuable it is to be stayed updated with day to day dynamic industry sectors. Recently Published Other Reports: 1. Germany Insights: Healthcare Industry, Policies, Regulations and PESTLE Analysis https://www.gervanora.com/ 2. Rheumatoid Arthritis: Global Market Analysis 2016 and Forecast 2017-2027 https:// 3. Bronchoscopes: https://www.gervanora.com/ 4. Colonoscopes: https://www.gervanora.com/ GervanoRA even provides the subscription based services like: · Deals and Acquisitions Database & Analytics (Only $100/ month) https://www.gervanora.com/ · Emerging Technologies Database & Analytics (Only $100 per month) https://www.gervanora.com/ · GervanoRA 360[o] PharmMedTech Monthly Bulletin (Only $100 per month) https://www.gervanora.com/ To find out more about GervanoRA, please visit: http://www.gervanora.com End
|
| |||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number